Although not considered an oncogene [46], elevated blood IGF-1 levels, and more importantly, local or peritumoral IGF-1 levels [47,48,49], have been associated with poor prognosis, increased tumor growth, and resistance to cytotoxic therapy. Here, IGF1 is linked to neoplasm.